N Wride, T Finch, T Rapley, T Moreira, C May, S … - British Medical …, 2007 - bjo.bmj.com To ensure that patients benefit as much as possible from the treatment prescribed to them,
we, as physicians, must consider some of the new and novel approaches to medication-taking
behaviour. We will present a brief overview of this topic and discuss some of the ... Related articles - BL Direct - All 3 versions
[CITATION] Detention institutes for ignorant and vicious consumptives
BW Jenkins - GP, 1954 - ncbi.nlm.nih.gov 1: GP. 1954 Jun;9(6):66-9. Are patients true to tid and qid doses? JENKINS BW. Mesh Terms:
Drug Prescriptions*; Patients*; Therapeutics*. PMID: 13162056 [PubMed - indexed for MEDLINE].
Cited by 13 - Related articles
- ►nih.gov [PDF] C Northrop, JH Fountain, DW Zahn - Public Health Reports, 1952 - pubmedcentral.nih.gov The first step in the prevention of recalci- trance is to have enough sanatorium beds avail- able
for the immediate care of all persons who have active tuberculosis. These beds should be located
in reasonably attractive, conven- iently located sanatoriums, staffed by competent and ... Cited by 12 - Related articles - All 4 versions
J Steiner, M Earnest - Improving medication adherence: how to talk …, 2006 - books.google.com Is It Really " Noncompliance"? " Words make a difference. The terms compliance and adherence
should be abandoned because they subtly exag- gerate the importance of the clinician, describe
behavior inaccurately, and shed little light on motivations."' John Steiner, MD, MPH Mark ... Related articles
- ►ajph.org [PDF] BH Lerner - American Journal of Public Health, 1996 - Am Public Health Assoc The recent resurgence of tuberculo- sis has generated great concern about patients who do
not complete their pre- scribed therapy. Not only do such individu- als remain reservoirs of
infection, but their erratic compliance has fostered the development of multidrug-resistant ... Cited by 19 - Related articles - BL Direct - All 4 versions
M Markman - Current Oncology Reports, 2006 - Springer One of the most important but relatively infrequently discussed aspects of the paradigm shift in
oncology from less specific cytotoxic treatment to more “targeted” cyto- static agents, selected
for their ability to inhibit unique molecular abnormalities, is the concept of long-term “ ... Related articles - BL Direct - All 2 versions
MV Kalayoglu, M Reppucci, TF Blaschke, LN … - American Journal of …, 2009 - ajmc.com Practical Implications • p 93 Author Information • p 94 Full text and PDF • www.ajpblive.com ...
92 The American Journal of Pharmacy Benefits • Summer 2009 ... Intermittent Reinforce ment
(DIR), a reinforcement plat- form previously shown to increase adherence to pills by 33% ( ... Related articles - View as HTML
IM ADHERENCE - N Engl J Med, 2005 - prtl-drprd-web.nyc.gov In the US, nonadherence causes one-third to two- thirds of medication-related hospital
admissions4,5 and results in $100 billion in direct health care costs, $50 billion in lost
productivity, and >$1.5 billion in lost earnings.6,7 Nonadherence is also associated with ... Related articles - View as HTML - All 2 versions
